News
12-23-2019, 08:27 PM
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such as trastuzumab. Both types of drugs are major culprits in chemotherapy-induced heart disease.
More... (https://www.news-medical.net/news/20191223/Obesity-linked-to-increased-risk-of-cardiotoxicity-in-chemotherapy-treated-patients-with-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20191223/Obesity-linked-to-increased-risk-of-cardiotoxicity-in-chemotherapy-treated-patients-with-breast-cancer.aspx)